nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—ulcerative colitis—colon cancer	0.392	1	CtDrD
Dexamethasone—NR0B1—Vincristine—colon cancer	0.107	0.354	CbGbCtD
Dexamethasone—PTGS2—colon cancer	0.0932	0.54	CbGaD
Dexamethasone—ABCB1—colon cancer	0.0793	0.46	CbGaD
Dexamethasone—ABCB11—Vincristine—colon cancer	0.0213	0.0705	CbGbCtD
Dexamethasone—ABCC2—Irinotecan—colon cancer	0.0128	0.0424	CbGbCtD
Dexamethasone—CYP2A6—Fluorouracil—colon cancer	0.012	0.0398	CbGbCtD
Dexamethasone—ABCG2—Irinotecan—colon cancer	0.0116	0.0384	CbGbCtD
Dexamethasone—ABCC2—Vincristine—colon cancer	0.0112	0.0371	CbGbCtD
Dexamethasone—ABCG2—Fluorouracil—colon cancer	0.0111	0.0368	CbGbCtD
Dexamethasone—ABCG2—Vincristine—colon cancer	0.0101	0.0335	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.00857	0.0283	CbGbCtD
Dexamethasone—CYP3A7—Irinotecan—colon cancer	0.00857	0.0283	CbGbCtD
Dexamethasone—SLCO1A2—Methotrexate—colon cancer	0.0082	0.0271	CbGbCtD
Dexamethasone—CYP2B6—Irinotecan—colon cancer	0.00816	0.027	CbGbCtD
Dexamethasone—CYP3A7—Vincristine—colon cancer	0.00749	0.0248	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.00749	0.0248	CbGbCtD
Dexamethasone—CYP2C9—Capecitabine—colon cancer	0.00698	0.0231	CbGbCtD
Dexamethasone—ABCC2—Methotrexate—colon cancer	0.0068	0.0225	CbGbCtD
Dexamethasone—CYP3A5—Irinotecan—colon cancer	0.00643	0.0213	CbGbCtD
Dexamethasone—ABCG2—Methotrexate—colon cancer	0.00614	0.0203	CbGbCtD
Dexamethasone—CYP2C8—Fluorouracil—colon cancer	0.00593	0.0196	CbGbCtD
Dexamethasone—CYP3A5—Vincristine—colon cancer	0.00562	0.0186	CbGbCtD
Dexamethasone—ABCB1—Irinotecan—colon cancer	0.00419	0.0138	CbGbCtD
Dexamethasone—CYP2C9—Fluorouracil—colon cancer	0.00414	0.0137	CbGbCtD
Dexamethasone—ABCB11—bile—colon cancer	0.00372	0.105	CbGeAlD
Dexamethasone—ABCB1—Vincristine—colon cancer	0.00366	0.0121	CbGbCtD
Dexamethasone—CYP3A4—Irinotecan—colon cancer	0.00251	0.00829	CbGbCtD
Dexamethasone—ABCB1—Methotrexate—colon cancer	0.00222	0.00732	CbGbCtD
Dexamethasone—CYP3A4—Vincristine—colon cancer	0.00219	0.00725	CbGbCtD
Dexamethasone—ABCC2—bile—colon cancer	0.00189	0.0532	CbGeAlD
Dexamethasone—PLA2G1B—blood vessel—colon cancer	0.00141	0.0397	CbGeAlD
Dexamethasone—ANXA1—gall bladder—colon cancer	0.00101	0.0286	CbGeAlD
Dexamethasone—CYP4A11—renal system—colon cancer	0.000768	0.0216	CbGeAlD
Dexamethasone—PLA2G1B—epithelium—colon cancer	0.000686	0.0193	CbGeAlD
Dexamethasone—CYP3A43—liver—colon cancer	0.000659	0.0185	CbGeAlD
Dexamethasone—PGR—blood vessel—colon cancer	0.000649	0.0183	CbGeAlD
Dexamethasone—ANXA1—embryo—colon cancer	0.000643	0.0181	CbGeAlD
Dexamethasone—PLA2G1B—renal system—colon cancer	0.000636	0.0179	CbGeAlD
Dexamethasone—CYP4A11—digestive system—colon cancer	0.00063	0.0177	CbGeAlD
Dexamethasone—CYP4A11—vagina—colon cancer	0.000556	0.0157	CbGeAlD
Dexamethasone—ANXA1—epithelium—colon cancer	0.000525	0.0148	CbGeAlD
Dexamethasone—PLA2G1B—digestive system—colon cancer	0.000522	0.0147	CbGeAlD
Dexamethasone—ANXA1—smooth muscle tissue—colon cancer	0.000506	0.0142	CbGeAlD
Dexamethasone—ANXA1—renal system—colon cancer	0.000487	0.0137	CbGeAlD
Dexamethasone—CYP4A11—liver—colon cancer	0.000469	0.0132	CbGeAlD
Dexamethasone—CYP17A1—renal system—colon cancer	0.000436	0.0123	CbGeAlD
Dexamethasone—ABCB11—digestive system—colon cancer	0.000406	0.0114	CbGeAlD
Dexamethasone—ANXA1—lymphoid tissue—colon cancer	0.000404	0.0114	CbGeAlD
Dexamethasone—ANXA1—digestive system—colon cancer	0.000399	0.0112	CbGeAlD
Dexamethasone—ANXA1—bone marrow—colon cancer	0.000368	0.0104	CbGeAlD
Dexamethasone—ANXA1—vagina—colon cancer	0.000352	0.00992	CbGeAlD
Dexamethasone—PTGS2—endothelium—colon cancer	0.000351	0.00989	CbGeAlD
Dexamethasone—NR3C2—smooth muscle tissue—colon cancer	0.000327	0.00922	CbGeAlD
Dexamethasone—PTGS2—blood vessel—colon cancer	0.000324	0.00912	CbGeAlD
Dexamethasone—PGR—epithelium—colon cancer	0.000316	0.00889	CbGeAlD
Dexamethasone—NR3C2—renal system—colon cancer	0.000315	0.00887	CbGeAlD
Dexamethasone—PTGS2—gall bladder—colon cancer	0.000305	0.00858	CbGeAlD
Dexamethasone—PGR—smooth muscle tissue—colon cancer	0.000304	0.00857	CbGeAlD
Dexamethasone—ABCB11—liver—colon cancer	0.000302	0.00851	CbGeAlD
Dexamethasone—ANXA1—liver—colon cancer	0.000297	0.00837	CbGeAlD
Dexamethasone—CYP3A7—liver—colon cancer	0.000296	0.00833	CbGeAlD
Dexamethasone—SLCO1A2—renal system—colon cancer	0.00027	0.00761	CbGeAlD
Dexamethasone—CYP17A1—liver—colon cancer	0.000266	0.0075	CbGeAlD
Dexamethasone—NR3C2—digestive system—colon cancer	0.000258	0.00728	CbGeAlD
Dexamethasone—CYP1B1—smooth muscle tissue—colon cancer	0.000256	0.00721	CbGeAlD
Dexamethasone—ABCC2—renal system—colon cancer	0.000252	0.00708	CbGeAlD
Dexamethasone—CYP3A7-CYP3A51P—liver—colon cancer	0.000251	0.00708	CbGeAlD
Dexamethasone—CYP1B1—renal system—colon cancer	0.000246	0.00694	CbGeAlD
Dexamethasone—CYP2A6—vagina—colon cancer	0.000244	0.00686	CbGeAlD
Dexamethasone—PGR—lymphoid tissue—colon cancer	0.000243	0.00685	CbGeAlD
Dexamethasone—NR3C2—vagina—colon cancer	0.000228	0.00643	CbGeAlD
Dexamethasone—ANXA1—lymph node—colon cancer	0.000228	0.00642	CbGeAlD
Dexamethasone—NR3C1—embryo—colon cancer	0.000223	0.00629	CbGeAlD
Dexamethasone—SLCO1A2—digestive system—colon cancer	0.000222	0.00624	CbGeAlD
Dexamethasone—PGR—vagina—colon cancer	0.000212	0.00597	CbGeAlD
Dexamethasone—ABCC2—digestive system—colon cancer	0.000206	0.00581	CbGeAlD
Dexamethasone—CYP2A6—liver—colon cancer	0.000205	0.00578	CbGeAlD
Dexamethasone—CYP1B1—lymphoid tissue—colon cancer	0.000205	0.00576	CbGeAlD
Dexamethasone—CYP17A1—lymph node—colon cancer	0.000204	0.00575	CbGeAlD
Dexamethasone—CYP1B1—digestive system—colon cancer	0.000202	0.00569	CbGeAlD
Dexamethasone—ABCB1—blood vessel—colon cancer	0.0002	0.00564	CbGeAlD
Dexamethasone—PTGS2—embryo—colon cancer	0.000193	0.00544	CbGeAlD
Dexamethasone—NR3C2—liver—colon cancer	0.000193	0.00542	CbGeAlD
Dexamethasone—CYP11A1—lymph node—colon cancer	0.00019	0.00535	CbGeAlD
Dexamethasone—CYP2C8—renal system—colon cancer	0.000189	0.00531	CbGeAlD
Dexamethasone—CYP1A1—epithelium—colon cancer	0.000188	0.00529	CbGeAlD
Dexamethasone—NR3C1—epithelium—colon cancer	0.000182	0.00513	CbGeAlD
Dexamethasone—CYP2C19—digestive system—colon cancer	0.000177	0.00499	CbGeAlD
Dexamethasone—NR3C1—smooth muscle tissue—colon cancer	0.000176	0.00494	CbGeAlD
Dexamethasone—CYP1A1—renal system—colon cancer	0.000174	0.0049	CbGeAlD
Dexamethasone—CYP3A5—renal system—colon cancer	0.00017	0.0048	CbGeAlD
Dexamethasone—CYP2B6—renal system—colon cancer	0.000169	0.00477	CbGeAlD
Dexamethasone—NR3C1—renal system—colon cancer	0.000169	0.00476	CbGeAlD
Dexamethasone—SLCO1A2—liver—colon cancer	0.000165	0.00465	CbGeAlD
Dexamethasone—CYP19A1—liver—colon cancer	0.000161	0.00454	CbGeAlD
Dexamethasone—CYP2E1—renal system—colon cancer	0.000159	0.00447	CbGeAlD
Dexamethasone—Weight decreased—Vincristine—colon cancer	0.000158	0.00284	CcSEcCtD
Dexamethasone—PTGS2—epithelium—colon cancer	0.000158	0.00444	CbGeAlD
Dexamethasone—CYP2C19—vagina—colon cancer	0.000157	0.00441	CbGeAlD
Dexamethasone—Extravasation—Methotrexate—colon cancer	0.000155	0.00278	CcSEcCtD
Dexamethasone—Weight decreased—Irinotecan—colon cancer	0.000154	0.00277	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Vincristine—colon cancer	0.000154	0.00276	CcSEcCtD
Dexamethasone—ABCC2—liver—colon cancer	0.000154	0.00433	CbGeAlD
Dexamethasone—Neuropathy peripheral—Vincristine—colon cancer	0.000153	0.00275	CcSEcCtD
Dexamethasone—Myocardial infarction—Vincristine—colon cancer	0.000153	0.00275	CcSEcCtD
Dexamethasone—Thrombophlebitis—Capecitabine—colon cancer	0.000152	0.00274	CcSEcCtD
Dexamethasone—PTGS2—smooth muscle tissue—colon cancer	0.000152	0.00428	CbGeAlD
Dexamethasone—Diabetes mellitus—Capecitabine—colon cancer	0.000152	0.00272	CcSEcCtD
Dexamethasone—CYP1B1—liver—colon cancer	0.000151	0.00424	CbGeAlD
Dexamethasone—Acute coronary syndrome—Irinotecan—colon cancer	0.00015	0.00269	CcSEcCtD
Dexamethasone—Myocardial infarction—Irinotecan—colon cancer	0.000149	0.00267	CcSEcCtD
Dexamethasone—NR3C2—lymph node—colon cancer	0.000148	0.00416	CbGeAlD
Dexamethasone—Herpes simplex—Methotrexate—colon cancer	0.000147	0.00264	CcSEcCtD
Dexamethasone—PTGS2—renal system—colon cancer	0.000146	0.00412	CbGeAlD
Dexamethasone—Eye pain—Capecitabine—colon cancer	0.000146	0.00262	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Fluorouracil—colon cancer	0.000144	0.00258	CcSEcCtD
Dexamethasone—Ulcer—Methotrexate—colon cancer	0.000143	0.00257	CcSEcCtD
Dexamethasone—CYP1A1—digestive system—colon cancer	0.000143	0.00402	CbGeAlD
Dexamethasone—Myocardial infarction—Fluorouracil—colon cancer	0.000143	0.00256	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Fluorouracil—colon cancer	0.000143	0.00256	CcSEcCtD
Dexamethasone—Conjunctivitis—Fluorouracil—colon cancer	0.000141	0.00254	CcSEcCtD
Dexamethasone—CYP2B6—lymphoid tissue—colon cancer	0.000141	0.00396	CbGeAlD
Dexamethasone—Increased appetite—Capecitabine—colon cancer	0.00014	0.00252	CcSEcCtD
Dexamethasone—NR3C1—lymphoid tissue—colon cancer	0.00014	0.00395	CbGeAlD
Dexamethasone—CYP3A5—digestive system—colon cancer	0.00014	0.00393	CbGeAlD
Dexamethasone—Hallucination—Vincristine—colon cancer	0.000139	0.0025	CcSEcCtD
Dexamethasone—Bradycardia—Irinotecan—colon cancer	0.000139	0.00249	CcSEcCtD
Dexamethasone—CYP2B6—digestive system—colon cancer	0.000139	0.00391	CbGeAlD
Dexamethasone—ABCG2—bone marrow—colon cancer	0.000139	0.00391	CbGeAlD
Dexamethasone—Vasculitis—Methotrexate—colon cancer	0.000139	0.00249	CcSEcCtD
Dexamethasone—NR3C1—digestive system—colon cancer	0.000139	0.0039	CbGeAlD
Dexamethasone—Dermatitis bullous—Capecitabine—colon cancer	0.000138	0.00248	CcSEcCtD
Dexamethasone—CYP2C9—digestive system—colon cancer	0.000137	0.00387	CbGeAlD
Dexamethasone—PGR—lymph node—colon cancer	0.000137	0.00386	CbGeAlD
Dexamethasone—Haemoglobin—Irinotecan—colon cancer	0.000137	0.00246	CcSEcCtD
Dexamethasone—CYP2C8—vagina—colon cancer	0.000137	0.00385	CbGeAlD
Dexamethasone—Haemorrhage—Irinotecan—colon cancer	0.000136	0.00245	CcSEcCtD
Dexamethasone—Cardiac failure—Capecitabine—colon cancer	0.000135	0.00243	CcSEcCtD
Dexamethasone—Lethargy—Capecitabine—colon cancer	0.000135	0.00242	CcSEcCtD
Dexamethasone—ABCG2—vagina—colon cancer	0.000133	0.00374	CbGeAlD
Dexamethasone—CYP2C19—liver—colon cancer	0.000132	0.00372	CbGeAlD
Dexamethasone—Osteoarthritis—Capecitabine—colon cancer	0.000132	0.00237	CcSEcCtD
Dexamethasone—CYP2E1—lymphoid tissue—colon cancer	0.000132	0.00371	CbGeAlD
Dexamethasone—Visual impairment—Irinotecan—colon cancer	0.000131	0.00236	CcSEcCtD
Dexamethasone—Haemoglobin—Fluorouracil—colon cancer	0.000131	0.00236	CcSEcCtD
Dexamethasone—Haemorrhage—Fluorouracil—colon cancer	0.000131	0.00235	CcSEcCtD
Dexamethasone—CYP2E1—digestive system—colon cancer	0.00013	0.00367	CbGeAlD
Dexamethasone—Migraine—Capecitabine—colon cancer	0.00013	0.00233	CcSEcCtD
Dexamethasone—Skin exfoliation—Methotrexate—colon cancer	0.000129	0.00232	CcSEcCtD
Dexamethasone—CYP3A4—renal system—colon cancer	0.000128	0.0036	CbGeAlD
Dexamethasone—NR3C1—bone marrow—colon cancer	0.000128	0.0036	CbGeAlD
Dexamethasone—Angiopathy—Vincristine—colon cancer	0.000127	0.00228	CcSEcCtD
Dexamethasone—CYP1A1—vagina—colon cancer	0.000126	0.00355	CbGeAlD
Dexamethasone—Irritability—Capecitabine—colon cancer	0.000126	0.00226	CcSEcCtD
Dexamethasone—CYP2D6—renal system—colon cancer	0.000126	0.00354	CbGeAlD
Dexamethasone—Cardiac arrest—Capecitabine—colon cancer	0.000126	0.00225	CcSEcCtD
Dexamethasone—Mood swings—Capecitabine—colon cancer	0.000125	0.00224	CcSEcCtD
Dexamethasone—Alopecia—Vincristine—colon cancer	0.000124	0.00222	CcSEcCtD
Dexamethasone—Angiopathy—Irinotecan—colon cancer	0.000124	0.00222	CcSEcCtD
Dexamethasone—CYP19A1—lymph node—colon cancer	0.000123	0.00348	CbGeAlD
Dexamethasone—CYP3A5—vagina—colon cancer	0.000123	0.00347	CbGeAlD
Dexamethasone—CYP2B6—vagina—colon cancer	0.000123	0.00345	CbGeAlD
Dexamethasone—NR3C1—vagina—colon cancer	0.000122	0.00345	CbGeAlD
Dexamethasone—Ecchymosis—Methotrexate—colon cancer	0.000122	0.0022	CcSEcCtD
Dexamethasone—Arrhythmia—Irinotecan—colon cancer	0.000122	0.00219	CcSEcCtD
Dexamethasone—PTGS2—lymphoid tissue—colon cancer	0.000121	0.00342	CbGeAlD
Dexamethasone—Dry skin—Capecitabine—colon cancer	0.000121	0.00217	CcSEcCtD
Dexamethasone—Alopecia—Irinotecan—colon cancer	0.000121	0.00216	CcSEcCtD
Dexamethasone—Pulmonary oedema—Methotrexate—colon cancer	0.00012	0.00216	CcSEcCtD
Dexamethasone—Hypokalaemia—Capecitabine—colon cancer	0.00012	0.00216	CcSEcCtD
Dexamethasone—PTGS2—digestive system—colon cancer	0.00012	0.00338	CbGeAlD
Dexamethasone—ABCB1—embryo—colon cancer	0.00012	0.00337	CbGeAlD
Dexamethasone—ABCC2—lymph node—colon cancer	0.000118	0.00332	CbGeAlD
Dexamethasone—Arrhythmia—Fluorouracil—colon cancer	0.000117	0.0021	CcSEcCtD
Dexamethasone—Muscular weakness—Capecitabine—colon cancer	0.000116	0.00209	CcSEcCtD
Dexamethasone—Alopecia—Fluorouracil—colon cancer	0.000115	0.00207	CcSEcCtD
Dexamethasone—CYP1B1—lymph node—colon cancer	0.000115	0.00325	CbGeAlD
Dexamethasone—CYP2C8—liver—colon cancer	0.000115	0.00325	CbGeAlD
Dexamethasone—Erythema—Fluorouracil—colon cancer	0.000114	0.00204	CcSEcCtD
Dexamethasone—Thrombophlebitis—Methotrexate—colon cancer	0.000114	0.00204	CcSEcCtD
Dexamethasone—Diabetes mellitus—Methotrexate—colon cancer	0.000113	0.00203	CcSEcCtD
Dexamethasone—ABCG2—liver—colon cancer	0.000112	0.00316	CbGeAlD
Dexamethasone—Sweating increased—Capecitabine—colon cancer	0.000111	0.00199	CcSEcCtD
Dexamethasone—PTGS2—bone marrow—colon cancer	0.000111	0.00311	CbGeAlD
Dexamethasone—Ill-defined disorder—Irinotecan—colon cancer	0.00011	0.00198	CcSEcCtD
Dexamethasone—Vertigo—Vincristine—colon cancer	0.00011	0.00197	CcSEcCtD
Dexamethasone—Malaise—Irinotecan—colon cancer	0.000107	0.00192	CcSEcCtD
Dexamethasone—Vertigo—Irinotecan—colon cancer	0.000107	0.00192	CcSEcCtD
Dexamethasone—Syncope—Irinotecan—colon cancer	0.000107	0.00191	CcSEcCtD
Dexamethasone—CYP1A1—liver—colon cancer	0.000106	0.003	CbGeAlD
Dexamethasone—PTGS2—vagina—colon cancer	0.000106	0.00298	CbGeAlD
Dexamethasone—Convulsion—Vincristine—colon cancer	0.000106	0.0019	CcSEcCtD
Dexamethasone—Hypertension—Vincristine—colon cancer	0.000105	0.00189	CcSEcCtD
Dexamethasone—CYP3A4—digestive system—colon cancer	0.000105	0.00295	CbGeAlD
Dexamethasone—Loss of consciousness—Irinotecan—colon cancer	0.000104	0.00187	CcSEcCtD
Dexamethasone—CYP3A5—liver—colon cancer	0.000104	0.00293	CbGeAlD
Dexamethasone—Myalgia—Vincristine—colon cancer	0.000104	0.00186	CcSEcCtD
Dexamethasone—Weight increased—Capecitabine—colon cancer	0.000104	0.00186	CcSEcCtD
Dexamethasone—Visual disturbance—Methotrexate—colon cancer	0.000104	0.00186	CcSEcCtD
Dexamethasone—CYP2B6—liver—colon cancer	0.000103	0.00291	CbGeAlD
Dexamethasone—NR3C1—liver—colon cancer	0.000103	0.00291	CbGeAlD
Dexamethasone—Weight decreased—Capecitabine—colon cancer	0.000103	0.00185	CcSEcCtD
Dexamethasone—CYP2D6—digestive system—colon cancer	0.000103	0.0029	CbGeAlD
Dexamethasone—Hyperglycaemia—Capecitabine—colon cancer	0.000103	0.00185	CcSEcCtD
Dexamethasone—Fluticasone furoate—ABCB1—colon cancer	0.000103	0.186	CrCbGaD
Dexamethasone—Hypertension—Irinotecan—colon cancer	0.000103	0.00184	CcSEcCtD
Dexamethasone—CYP2C9—liver—colon cancer	0.000102	0.00288	CbGeAlD
Dexamethasone—Anaphylactoid reaction—Methotrexate—colon cancer	0.000102	0.00182	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Capecitabine—colon cancer	0.0001	0.0018	CcSEcCtD
Dexamethasone—Lethargy—Methotrexate—colon cancer	0.0001	0.0018	CcSEcCtD
Dexamethasone—Discomfort—Irinotecan—colon cancer	9.99e-05	0.00179	CcSEcCtD
Dexamethasone—Myocardial infarction—Capecitabine—colon cancer	9.97e-05	0.00179	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Capecitabine—colon cancer	9.97e-05	0.00179	CcSEcCtD
Dexamethasone—Oedema—Vincristine—colon cancer	9.95e-05	0.00179	CcSEcCtD
Dexamethasone—Anaphylactic shock—Vincristine—colon cancer	9.95e-05	0.00179	CcSEcCtD
Dexamethasone—Infection—Vincristine—colon cancer	9.89e-05	0.00177	CcSEcCtD
Dexamethasone—Conjunctivitis—Capecitabine—colon cancer	9.89e-05	0.00177	CcSEcCtD
Dexamethasone—Convulsion—Fluorouracil—colon cancer	9.86e-05	0.00177	CcSEcCtD
Dexamethasone—Osteoarthritis—Methotrexate—colon cancer	9.83e-05	0.00176	CcSEcCtD
Dexamethasone—Nervous system disorder—Vincristine—colon cancer	9.76e-05	0.00175	CcSEcCtD
Dexamethasone—ABCB1—epithelium—colon cancer	9.76e-05	0.00275	CbGeAlD
Dexamethasone—Thrombocytopenia—Vincristine—colon cancer	9.75e-05	0.00175	CcSEcCtD
Dexamethasone—CYP2E1—liver—colon cancer	9.71e-05	0.00273	CbGeAlD
Dexamethasone—Oedema—Irinotecan—colon cancer	9.69e-05	0.00174	CcSEcCtD
Dexamethasone—Anaphylactic shock—Irinotecan—colon cancer	9.69e-05	0.00174	CcSEcCtD
Dexamethasone—Myalgia—Fluorouracil—colon cancer	9.68e-05	0.00174	CcSEcCtD
Dexamethasone—Infection—Irinotecan—colon cancer	9.63e-05	0.00173	CcSEcCtD
Dexamethasone—Hyperhidrosis—Vincristine—colon cancer	9.62e-05	0.00173	CcSEcCtD
Dexamethasone—Discomfort—Fluorouracil—colon cancer	9.57e-05	0.00172	CcSEcCtD
Dexamethasone—Shock—Irinotecan—colon cancer	9.54e-05	0.00171	CcSEcCtD
Dexamethasone—Nervous system disorder—Irinotecan—colon cancer	9.51e-05	0.00171	CcSEcCtD
Dexamethasone—Thrombocytopenia—Irinotecan—colon cancer	9.49e-05	0.0017	CcSEcCtD
Dexamethasone—Anorexia—Vincristine—colon cancer	9.49e-05	0.0017	CcSEcCtD
Dexamethasone—Irritability—Methotrexate—colon cancer	9.38e-05	0.00168	CcSEcCtD
Dexamethasone—Hyperhidrosis—Irinotecan—colon cancer	9.37e-05	0.00168	CcSEcCtD
Dexamethasone—Mood swings—Methotrexate—colon cancer	9.31e-05	0.00167	CcSEcCtD
Dexamethasone—Hypotension—Vincristine—colon cancer	9.3e-05	0.00167	CcSEcCtD
Dexamethasone—Bradycardia—Capecitabine—colon cancer	9.3e-05	0.00167	CcSEcCtD
Dexamethasone—Oedema—Fluorouracil—colon cancer	9.28e-05	0.00167	CcSEcCtD
Dexamethasone—Anaphylactic shock—Fluorouracil—colon cancer	9.28e-05	0.00167	CcSEcCtD
Dexamethasone—Anorexia—Irinotecan—colon cancer	9.24e-05	0.00166	CcSEcCtD
Dexamethasone—Infection—Fluorouracil—colon cancer	9.22e-05	0.00166	CcSEcCtD
Dexamethasone—Haemoglobin—Capecitabine—colon cancer	9.18e-05	0.00165	CcSEcCtD
Dexamethasone—Haemorrhage—Capecitabine—colon cancer	9.13e-05	0.00164	CcSEcCtD
Dexamethasone—Nervous system disorder—Fluorouracil—colon cancer	9.1e-05	0.00163	CcSEcCtD
Dexamethasone—Thrombocytopenia—Fluorouracil—colon cancer	9.09e-05	0.00163	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Vincristine—colon cancer	9.07e-05	0.00163	CcSEcCtD
Dexamethasone—Tachycardia—Fluorouracil—colon cancer	9.06e-05	0.00163	CcSEcCtD
Dexamethasone—Hypotension—Irinotecan—colon cancer	9.06e-05	0.00163	CcSEcCtD
Dexamethasone—ABCB1—renal system—colon cancer	9.05e-05	0.00255	CbGeAlD
Dexamethasone—Insomnia—Vincristine—colon cancer	9e-05	0.00162	CcSEcCtD
Dexamethasone—PTGS2—liver—colon cancer	8.94e-05	0.00252	CbGeAlD
Dexamethasone—Paraesthesia—Vincristine—colon cancer	8.94e-05	0.0016	CcSEcCtD
Dexamethasone—Anorexia—Fluorouracil—colon cancer	8.85e-05	0.00159	CcSEcCtD
Dexamethasone—Visual impairment—Capecitabine—colon cancer	8.8e-05	0.00158	CcSEcCtD
Dexamethasone—Insomnia—Irinotecan—colon cancer	8.77e-05	0.00157	CcSEcCtD
Dexamethasone—Paraesthesia—Irinotecan—colon cancer	8.7e-05	0.00156	CcSEcCtD
Dexamethasone—Hypotension—Fluorouracil—colon cancer	8.68e-05	0.00156	CcSEcCtD
Dexamethasone—Decreased appetite—Vincristine—colon cancer	8.65e-05	0.00155	CcSEcCtD
Dexamethasone—ABCG2—lymph node—colon cancer	8.6e-05	0.00242	CbGeAlD
Dexamethasone—Gastrointestinal disorder—Vincristine—colon cancer	8.59e-05	0.00154	CcSEcCtD
Dexamethasone—Fatigue—Vincristine—colon cancer	8.58e-05	0.00154	CcSEcCtD
Dexamethasone—Eye disorder—Capecitabine—colon cancer	8.53e-05	0.00153	CcSEcCtD
Dexamethasone—Dyspepsia—Irinotecan—colon cancer	8.53e-05	0.00153	CcSEcCtD
Dexamethasone—Pain—Vincristine—colon cancer	8.51e-05	0.00153	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Fluorouracil—colon cancer	8.46e-05	0.00152	CcSEcCtD
Dexamethasone—Decreased appetite—Irinotecan—colon cancer	8.43e-05	0.00151	CcSEcCtD
Dexamethasone—Insomnia—Fluorouracil—colon cancer	8.4e-05	0.00151	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Irinotecan—colon cancer	8.37e-05	0.0015	CcSEcCtD
Dexamethasone—Fatigue—Irinotecan—colon cancer	8.36e-05	0.0015	CcSEcCtD
Dexamethasone—Paraesthesia—Fluorouracil—colon cancer	8.34e-05	0.0015	CcSEcCtD
Dexamethasone—Pain—Irinotecan—colon cancer	8.29e-05	0.00149	CcSEcCtD
Dexamethasone—Angiopathy—Capecitabine—colon cancer	8.29e-05	0.00149	CcSEcCtD
Dexamethasone—Methylprednisolone—ABCB1—colon cancer	8.18e-05	0.148	CrCbGaD
Dexamethasone—Dyspepsia—Fluorouracil—colon cancer	8.17e-05	0.00147	CcSEcCtD
Dexamethasone—CYP1A1—lymph node—colon cancer	8.16e-05	0.0023	CbGeAlD
Dexamethasone—Arrhythmia—Capecitabine—colon cancer	8.16e-05	0.00146	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Vincristine—colon cancer	8.14e-05	0.00146	CcSEcCtD
Dexamethasone—Triamcinolone—PTGS2—colon cancer	8.11e-05	0.147	CrCbGaD
Dexamethasone—Decreased appetite—Fluorouracil—colon cancer	8.07e-05	0.00145	CcSEcCtD
Dexamethasone—Alopecia—Capecitabine—colon cancer	8.07e-05	0.00145	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Fluorouracil—colon cancer	8.02e-05	0.00144	CcSEcCtD
Dexamethasone—Feeling abnormal—Irinotecan—colon cancer	7.99e-05	0.00143	CcSEcCtD
Dexamethasone—Erythema—Capecitabine—colon cancer	7.95e-05	0.00143	CcSEcCtD
Dexamethasone—Pain—Fluorouracil—colon cancer	7.94e-05	0.00142	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Irinotecan—colon cancer	7.93e-05	0.00142	CcSEcCtD
Dexamethasone—NR3C1—lymph node—colon cancer	7.92e-05	0.00223	CbGeAlD
Dexamethasone—Body temperature increased—Vincristine—colon cancer	7.87e-05	0.00141	CcSEcCtD
Dexamethasone—Abdominal pain—Vincristine—colon cancer	7.87e-05	0.00141	CcSEcCtD
Dexamethasone—CYP3A4—liver—colon cancer	7.81e-05	0.0022	CbGeAlD
Dexamethasone—CYP2D6—liver—colon cancer	7.69e-05	0.00216	CbGeAlD
Dexamethasone—Abdominal pain—Irinotecan—colon cancer	7.66e-05	0.00138	CcSEcCtD
Dexamethasone—Body temperature increased—Irinotecan—colon cancer	7.66e-05	0.00138	CcSEcCtD
Dexamethasone—Feeling abnormal—Fluorouracil—colon cancer	7.65e-05	0.00137	CcSEcCtD
Dexamethasone—ABCB1—lymphoid tissue—colon cancer	7.51e-05	0.00212	CbGeAlD
Dexamethasone—ABCB1—digestive system—colon cancer	7.42e-05	0.00209	CbGeAlD
Dexamethasone—Ill-defined disorder—Capecitabine—colon cancer	7.38e-05	0.00132	CcSEcCtD
Dexamethasone—Urticaria—Fluorouracil—colon cancer	7.38e-05	0.00132	CcSEcCtD
Dexamethasone—Conjunctivitis—Methotrexate—colon cancer	7.36e-05	0.00132	CcSEcCtD
Dexamethasone—Body temperature increased—Fluorouracil—colon cancer	7.34e-05	0.00132	CcSEcCtD
Dexamethasone—Malaise—Capecitabine—colon cancer	7.17e-05	0.00129	CcSEcCtD
Dexamethasone—Vertigo—Capecitabine—colon cancer	7.14e-05	0.00128	CcSEcCtD
Dexamethasone—Asthenia—Vincristine—colon cancer	7.14e-05	0.00128	CcSEcCtD
Dexamethasone—Syncope—Capecitabine—colon cancer	7.13e-05	0.00128	CcSEcCtD
Dexamethasone—Loss of consciousness—Capecitabine—colon cancer	6.99e-05	0.00125	CcSEcCtD
Dexamethasone—Asthenia—Irinotecan—colon cancer	6.96e-05	0.00125	CcSEcCtD
Dexamethasone—Hypertension—Capecitabine—colon cancer	6.86e-05	0.00123	CcSEcCtD
Dexamethasone—PTGS2—lymph node—colon cancer	6.85e-05	0.00193	CbGeAlD
Dexamethasone—ABCB1—bone marrow—colon cancer	6.84e-05	0.00193	CbGeAlD
Dexamethasone—Haemoglobin—Methotrexate—colon cancer	6.83e-05	0.00123	CcSEcCtD
Dexamethasone—Diarrhoea—Vincristine—colon cancer	6.81e-05	0.00122	CcSEcCtD
Dexamethasone—Haemorrhage—Methotrexate—colon cancer	6.8e-05	0.00122	CcSEcCtD
Dexamethasone—Myalgia—Capecitabine—colon cancer	6.77e-05	0.00121	CcSEcCtD
Dexamethasone—Anxiety—Capecitabine—colon cancer	6.74e-05	0.00121	CcSEcCtD
Dexamethasone—Discomfort—Capecitabine—colon cancer	6.69e-05	0.0012	CcSEcCtD
Dexamethasone—Betamethasone—PTGS2—colon cancer	6.64e-05	0.12	CrCbGaD
Dexamethasone—Diarrhoea—Irinotecan—colon cancer	6.63e-05	0.00119	CcSEcCtD
Dexamethasone—Dizziness—Vincristine—colon cancer	6.58e-05	0.00118	CcSEcCtD
Dexamethasone—Pruritus—Fluorouracil—colon cancer	6.57e-05	0.00118	CcSEcCtD
Dexamethasone—ABCB1—vagina—colon cancer	6.55e-05	0.00185	CbGeAlD
Dexamethasone—Visual impairment—Methotrexate—colon cancer	6.55e-05	0.00118	CcSEcCtD
Dexamethasone—Oedema—Capecitabine—colon cancer	6.49e-05	0.00116	CcSEcCtD
Dexamethasone—Infection—Capecitabine—colon cancer	6.45e-05	0.00116	CcSEcCtD
Dexamethasone—Dizziness—Irinotecan—colon cancer	6.41e-05	0.00115	CcSEcCtD
Dexamethasone—Shock—Capecitabine—colon cancer	6.38e-05	0.00115	CcSEcCtD
Dexamethasone—Nervous system disorder—Capecitabine—colon cancer	6.36e-05	0.00114	CcSEcCtD
Dexamethasone—Eye disorder—Methotrexate—colon cancer	6.35e-05	0.00114	CcSEcCtD
Dexamethasone—Diarrhoea—Fluorouracil—colon cancer	6.35e-05	0.00114	CcSEcCtD
Dexamethasone—Thrombocytopenia—Capecitabine—colon cancer	6.35e-05	0.00114	CcSEcCtD
Dexamethasone—Tachycardia—Capecitabine—colon cancer	6.33e-05	0.00114	CcSEcCtD
Dexamethasone—Vomiting—Vincristine—colon cancer	6.33e-05	0.00114	CcSEcCtD
Dexamethasone—Rash—Vincristine—colon cancer	6.28e-05	0.00113	CcSEcCtD
Dexamethasone—Hyperhidrosis—Capecitabine—colon cancer	6.27e-05	0.00113	CcSEcCtD
Dexamethasone—Dermatitis—Vincristine—colon cancer	6.27e-05	0.00113	CcSEcCtD
Dexamethasone—Prednisone—ABCB1—colon cancer	6.25e-05	0.113	CrCbGaD
Dexamethasone—Headache—Vincristine—colon cancer	6.24e-05	0.00112	CcSEcCtD
Dexamethasone—Anorexia—Capecitabine—colon cancer	6.18e-05	0.00111	CcSEcCtD
Dexamethasone—Angiopathy—Methotrexate—colon cancer	6.17e-05	0.00111	CcSEcCtD
Dexamethasone—Vomiting—Irinotecan—colon cancer	6.16e-05	0.00111	CcSEcCtD
Dexamethasone—Dizziness—Fluorouracil—colon cancer	6.14e-05	0.0011	CcSEcCtD
Dexamethasone—Rash—Irinotecan—colon cancer	6.11e-05	0.0011	CcSEcCtD
Dexamethasone—Dermatitis—Irinotecan—colon cancer	6.11e-05	0.0011	CcSEcCtD
Dexamethasone—Headache—Irinotecan—colon cancer	6.07e-05	0.00109	CcSEcCtD
Dexamethasone—Hypotension—Capecitabine—colon cancer	6.06e-05	0.00109	CcSEcCtD
Dexamethasone—Alopecia—Methotrexate—colon cancer	6.01e-05	0.00108	CcSEcCtD
Dexamethasone—Erythema—Methotrexate—colon cancer	5.92e-05	0.00106	CcSEcCtD
Dexamethasone—Nausea—Vincristine—colon cancer	5.91e-05	0.00106	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Capecitabine—colon cancer	5.91e-05	0.00106	CcSEcCtD
Dexamethasone—Vomiting—Fluorouracil—colon cancer	5.9e-05	0.00106	CcSEcCtD
Dexamethasone—Insomnia—Capecitabine—colon cancer	5.87e-05	0.00105	CcSEcCtD
Dexamethasone—Rash—Fluorouracil—colon cancer	5.85e-05	0.00105	CcSEcCtD
Dexamethasone—Dermatitis—Fluorouracil—colon cancer	5.85e-05	0.00105	CcSEcCtD
Dexamethasone—Paraesthesia—Capecitabine—colon cancer	5.83e-05	0.00105	CcSEcCtD
Dexamethasone—Headache—Fluorouracil—colon cancer	5.82e-05	0.00104	CcSEcCtD
Dexamethasone—Prednisolone—ABCB1—colon cancer	5.76e-05	0.104	CrCbGaD
Dexamethasone—Nausea—Irinotecan—colon cancer	5.76e-05	0.00103	CcSEcCtD
Dexamethasone—Dyspepsia—Capecitabine—colon cancer	5.71e-05	0.00103	CcSEcCtD
Dexamethasone—Betamethasone—ABCB1—colon cancer	5.65e-05	0.102	CrCbGaD
Dexamethasone—Decreased appetite—Capecitabine—colon cancer	5.64e-05	0.00101	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Capecitabine—colon cancer	5.6e-05	0.00101	CcSEcCtD
Dexamethasone—Fatigue—Capecitabine—colon cancer	5.59e-05	0.001	CcSEcCtD
Dexamethasone—Pain—Capecitabine—colon cancer	5.55e-05	0.000996	CcSEcCtD
Dexamethasone—ABCB1—liver—colon cancer	5.53e-05	0.00156	CbGeAlD
Dexamethasone—Nausea—Fluorouracil—colon cancer	5.51e-05	0.00099	CcSEcCtD
Dexamethasone—Ill-defined disorder—Methotrexate—colon cancer	5.49e-05	0.000985	CcSEcCtD
Dexamethasone—Feeling abnormal—Capecitabine—colon cancer	5.35e-05	0.00096	CcSEcCtD
Dexamethasone—Malaise—Methotrexate—colon cancer	5.34e-05	0.000958	CcSEcCtD
Dexamethasone—Vertigo—Methotrexate—colon cancer	5.32e-05	0.000954	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Capecitabine—colon cancer	5.31e-05	0.000952	CcSEcCtD
Dexamethasone—Urticaria—Capecitabine—colon cancer	5.15e-05	0.000925	CcSEcCtD
Dexamethasone—Body temperature increased—Capecitabine—colon cancer	5.13e-05	0.000921	CcSEcCtD
Dexamethasone—Abdominal pain—Capecitabine—colon cancer	5.13e-05	0.000921	CcSEcCtD
Dexamethasone—Convulsion—Methotrexate—colon cancer	5.13e-05	0.00092	CcSEcCtD
Dexamethasone—Myalgia—Methotrexate—colon cancer	5.04e-05	0.000904	CcSEcCtD
Dexamethasone—Discomfort—Methotrexate—colon cancer	4.98e-05	0.000893	CcSEcCtD
Dexamethasone—Anaphylactic shock—Methotrexate—colon cancer	4.83e-05	0.000867	CcSEcCtD
Dexamethasone—Infection—Methotrexate—colon cancer	4.8e-05	0.000861	CcSEcCtD
Dexamethasone—Nervous system disorder—Methotrexate—colon cancer	4.74e-05	0.00085	CcSEcCtD
Dexamethasone—Thrombocytopenia—Methotrexate—colon cancer	4.73e-05	0.000849	CcSEcCtD
Dexamethasone—Hyperhidrosis—Methotrexate—colon cancer	4.67e-05	0.000838	CcSEcCtD
Dexamethasone—Asthenia—Capecitabine—colon cancer	4.65e-05	0.000835	CcSEcCtD
Dexamethasone—Anorexia—Methotrexate—colon cancer	4.6e-05	0.000826	CcSEcCtD
Dexamethasone—Pruritus—Capecitabine—colon cancer	4.59e-05	0.000824	CcSEcCtD
Dexamethasone—Hypotension—Methotrexate—colon cancer	4.51e-05	0.00081	CcSEcCtD
Dexamethasone—Diarrhoea—Capecitabine—colon cancer	4.44e-05	0.000797	CcSEcCtD
Dexamethasone—Hydrocortisone—ABCB1—colon cancer	4.41e-05	0.0798	CrCbGaD
Dexamethasone—Musculoskeletal discomfort—Methotrexate—colon cancer	4.4e-05	0.00079	CcSEcCtD
Dexamethasone—Insomnia—Methotrexate—colon cancer	4.37e-05	0.000784	CcSEcCtD
Dexamethasone—Paraesthesia—Methotrexate—colon cancer	4.34e-05	0.000778	CcSEcCtD
Dexamethasone—Dizziness—Capecitabine—colon cancer	4.29e-05	0.00077	CcSEcCtD
Dexamethasone—Dyspepsia—Methotrexate—colon cancer	4.25e-05	0.000763	CcSEcCtD
Dexamethasone—ABCB1—lymph node—colon cancer	4.24e-05	0.00119	CbGeAlD
Dexamethasone—Decreased appetite—Methotrexate—colon cancer	4.2e-05	0.000754	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Methotrexate—colon cancer	4.17e-05	0.000748	CcSEcCtD
Dexamethasone—Fatigue—Methotrexate—colon cancer	4.16e-05	0.000747	CcSEcCtD
Dexamethasone—Pain—Methotrexate—colon cancer	4.13e-05	0.000741	CcSEcCtD
Dexamethasone—Vomiting—Capecitabine—colon cancer	4.13e-05	0.00074	CcSEcCtD
Dexamethasone—Rash—Capecitabine—colon cancer	4.09e-05	0.000734	CcSEcCtD
Dexamethasone—Dermatitis—Capecitabine—colon cancer	4.09e-05	0.000734	CcSEcCtD
Dexamethasone—Headache—Capecitabine—colon cancer	4.06e-05	0.000729	CcSEcCtD
Dexamethasone—Feeling abnormal—Methotrexate—colon cancer	3.98e-05	0.000714	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Methotrexate—colon cancer	3.95e-05	0.000709	CcSEcCtD
Dexamethasone—Nausea—Capecitabine—colon cancer	3.85e-05	0.000692	CcSEcCtD
Dexamethasone—Urticaria—Methotrexate—colon cancer	3.84e-05	0.000689	CcSEcCtD
Dexamethasone—Abdominal pain—Methotrexate—colon cancer	3.82e-05	0.000685	CcSEcCtD
Dexamethasone—Body temperature increased—Methotrexate—colon cancer	3.82e-05	0.000685	CcSEcCtD
Dexamethasone—Asthenia—Methotrexate—colon cancer	3.47e-05	0.000622	CcSEcCtD
Dexamethasone—Pruritus—Methotrexate—colon cancer	3.42e-05	0.000613	CcSEcCtD
Dexamethasone—Diarrhoea—Methotrexate—colon cancer	3.3e-05	0.000593	CcSEcCtD
Dexamethasone—Dizziness—Methotrexate—colon cancer	3.19e-05	0.000573	CcSEcCtD
Dexamethasone—Vomiting—Methotrexate—colon cancer	3.07e-05	0.000551	CcSEcCtD
Dexamethasone—Rash—Methotrexate—colon cancer	3.05e-05	0.000547	CcSEcCtD
Dexamethasone—Dermatitis—Methotrexate—colon cancer	3.04e-05	0.000546	CcSEcCtD
Dexamethasone—Headache—Methotrexate—colon cancer	3.03e-05	0.000543	CcSEcCtD
Dexamethasone—Nausea—Methotrexate—colon cancer	2.87e-05	0.000515	CcSEcCtD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	7.34e-06	0.000179	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCND1—colon cancer	7.31e-06	0.000178	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PPARG—colon cancer	7.27e-06	0.000177	CbGpPWpGaD
Dexamethasone—NOS2—Disease—EP300—colon cancer	7.24e-06	0.000177	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CTNNB1—colon cancer	7.24e-06	0.000176	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.23e-06	0.000176	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.16e-06	0.000175	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.16e-06	0.000174	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	7.14e-06	0.000174	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CDKN1A—colon cancer	7.07e-06	0.000172	CbGpPWpGaD
Dexamethasone—NOS2—Disease—SRC—colon cancer	7.04e-06	0.000172	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ABCB1—colon cancer	7.01e-06	0.000171	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CHST5—colon cancer	6.99e-06	0.00017	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ODC1—colon cancer	6.99e-06	0.00017	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	6.96e-06	0.000169	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—TYMS—colon cancer	6.88e-06	0.000168	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—AKT1—colon cancer	6.88e-06	0.000168	CbGpPWpGaD
Dexamethasone—NOS2—Disease—NRAS—colon cancer	6.78e-06	0.000165	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—EP300—colon cancer	6.73e-06	0.000164	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PPARG—colon cancer	6.65e-06	0.000162	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.61e-06	0.000161	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PPARG—colon cancer	6.59e-06	0.00016	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—SRC—colon cancer	6.54e-06	0.000159	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.47e-06	0.000158	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	6.4e-06	0.000156	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	6.38e-06	0.000156	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—VEGFA—colon cancer	6.37e-06	0.000155	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.35e-06	0.000155	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—FGFR3—colon cancer	6.34e-06	0.000155	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ABCB1—colon cancer	6.33e-06	0.000154	CbGpPWpGaD
Dexamethasone—NOS2—Disease—MYC—colon cancer	6.31e-06	0.000154	CbGpPWpGaD
Dexamethasone—NOS2—Disease—TGFB1—colon cancer	6.3e-06	0.000153	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—NRAS—colon cancer	6.29e-06	0.000153	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.26e-06	0.000153	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	6.26e-06	0.000153	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.23e-06	0.000152	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—TYMS—colon cancer	6.22e-06	0.000152	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—EP300—colon cancer	6.22e-06	0.000151	CbGpPWpGaD
Dexamethasone—NOS2—Disease—EGFR—colon cancer	6.17e-06	0.00015	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ABCB1—colon cancer	6.1e-06	0.000149	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—TYMS—colon cancer	5.99e-06	0.000146	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—MYC—colon cancer	5.92e-06	0.000144	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.91e-06	0.000144	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.87e-06	0.000143	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MYC—colon cancer	5.86e-06	0.000143	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TGFB1—colon cancer	5.85e-06	0.000142	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PPARG—colon cancer	5.84e-06	0.000142	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—PIK3CA—colon cancer	5.84e-06	0.000142	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KRAS—colon cancer	5.83e-06	0.000142	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—APC—colon cancer	5.82e-06	0.000142	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—EGFR—colon cancer	5.73e-06	0.00014	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PTGS2—colon cancer	5.72e-06	0.000139	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—AKT1—colon cancer	5.61e-06	0.000137	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ABCB1—colon cancer	5.55e-06	0.000135	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ABCB1—colon cancer	5.5e-06	0.000134	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—BRAF—colon cancer	5.47e-06	0.000133	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—TYMS—colon cancer	5.45e-06	0.000133	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	5.43e-06	0.000132	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KRAS—colon cancer	5.42e-06	0.000132	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—TYMS—colon cancer	5.4e-06	0.000132	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.38e-06	0.000131	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PIK3CA—colon cancer	5.36e-06	0.000131	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.3e-06	0.000129	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	5.26e-06	0.000128	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PTGS2—colon cancer	5.23e-06	0.000128	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PTGS2—colon cancer	5.18e-06	0.000126	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ABCB1—colon cancer	5.04e-06	0.000123	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—PPARG—colon cancer	5e-06	0.000122	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PIK3CA—colon cancer	4.98e-06	0.000121	CbGpPWpGaD
Dexamethasone—NOS2—Disease—HRAS—colon cancer	4.96e-06	0.000121	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—TYMS—colon cancer	4.95e-06	0.000121	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—MYC—colon cancer	4.93e-06	0.00012	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PPARG—colon cancer	4.88e-06	0.000119	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—colon cancer	4.81e-06	0.000117	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.8e-06	0.000117	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.79e-06	0.000117	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—AKT1—colon cancer	4.77e-06	0.000116	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—EP300—colon cancer	4.76e-06	0.000116	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.62e-06	0.000112	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.61e-06	0.000112	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—HRAS—colon cancer	4.6e-06	0.000112	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PIK3CA—colon cancer	4.6e-06	0.000112	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTGS2—colon cancer	4.59e-06	0.000112	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	4.44e-06	0.000108	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PPARG—colon cancer	4.41e-06	0.000107	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.38e-06	0.000107	CbGpPWpGaD
Dexamethasone—NOS2—Disease—AKT1—colon cancer	4.38e-06	0.000107	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—EP300—colon cancer	4.35e-06	0.000106	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.33e-06	0.000105	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—EP300—colon cancer	4.31e-06	0.000105	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PPARG—colon cancer	4.24e-06	0.000103	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ABCB1—colon cancer	4.23e-06	0.000103	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.23e-06	0.000103	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—TYMS—colon cancer	4.16e-06	0.000101	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CASP3—colon cancer	4.1e-06	0.0001	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ABCB1—colon cancer	4.07e-06	9.91e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—AKT1—colon cancer	4.06e-06	9.9e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCND1—colon cancer	4e-06	9.73e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—TYMS—colon cancer	4e-06	9.73e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ABCB1—colon cancer	3.98e-06	9.71e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ABCB1—colon cancer	3.98e-06	9.69e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FGFR3—colon cancer	3.97e-06	9.67e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CTNNB1—colon cancer	3.96e-06	9.64e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—TYMS—colon cancer	3.91e-06	9.53e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—TYMS—colon cancer	3.9e-06	9.51e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CDKN1A—colon cancer	3.86e-06	9.42e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PPARG—colon cancer	3.86e-06	9.41e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.84e-06	9.36e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTGS2—colon cancer	3.84e-06	9.35e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PPARG—colon cancer	3.83e-06	9.32e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—EP300—colon cancer	3.82e-06	9.31e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.78e-06	9.2e-05	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—AKT1—colon cancer	3.76e-06	9.15e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ABCB1—colon cancer	3.76e-06	9.15e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—TYMS—colon cancer	3.69e-06	8.99e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EP300—colon cancer	3.68e-06	8.96e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—APC—colon cancer	3.64e-06	8.88e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SRC—colon cancer	3.58e-06	8.71e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PIK3CA—colon cancer	3.52e-06	8.58e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.52e-06	8.58e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PPARG—colon cancer	3.51e-06	8.55e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—colon cancer	3.48e-06	8.49e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—colon cancer	3.47e-06	8.45e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.44e-06	8.39e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ABCB1—colon cancer	3.44e-06	8.39e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NRAS—colon cancer	3.44e-06	8.38e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—BRAF—colon cancer	3.42e-06	8.34e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—AKT1—colon cancer	3.42e-06	8.33e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—TYMS—colon cancer	3.38e-06	8.24e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—colon cancer	3.34e-06	8.13e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PIK3CA—colon cancer	3.22e-06	7.85e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—colon cancer	3.2e-06	7.81e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.2e-06	7.8e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TGFB1—colon cancer	3.2e-06	7.79e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—EP300—colon cancer	3.19e-06	7.77e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PIK3CA—colon cancer	3.19e-06	7.77e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.14e-06	7.66e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—colon cancer	3.13e-06	7.64e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ABCB1—colon cancer	3.07e-06	7.49e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—colon cancer	3.04e-06	7.4e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—TYMS—colon cancer	3.02e-06	7.36e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—colon cancer	3.01e-06	7.34e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—colon cancer	2.96e-06	7.21e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TYMS—colon cancer	2.95e-06	7.18e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PPARG—colon cancer	2.94e-06	7.17e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—EP300—colon cancer	2.88e-06	7.03e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—colon cancer	2.88e-06	7.01e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.86e-06	6.98e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—colon cancer	2.85e-06	6.94e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.84e-06	6.92e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PPARG—colon cancer	2.83e-06	6.9e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ABCB1—colon cancer	2.83e-06	6.89e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CA—colon cancer	2.83e-06	6.89e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ABCB1—colon cancer	2.8e-06	6.83e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TYMS—colon cancer	2.78e-06	6.77e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—EP300—colon cancer	2.78e-06	6.77e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PPARG—colon cancer	2.77e-06	6.75e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PPARG—colon cancer	2.77e-06	6.74e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—colon cancer	2.76e-06	6.72e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TYMS—colon cancer	2.75e-06	6.71e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CA—colon cancer	2.72e-06	6.63e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—colon cancer	2.63e-06	6.41e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—colon cancer	2.63e-06	6.41e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PPARG—colon cancer	2.61e-06	6.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.6e-06	6.34e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—colon cancer	2.6e-06	6.34e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—EP300—colon cancer	2.53e-06	6.15e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—colon cancer	2.52e-06	6.13e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—EP300—colon cancer	2.5e-06	6.1e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CTNNB1—colon cancer	2.47e-06	6.03e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1A—colon cancer	2.42e-06	5.89e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PPARG—colon cancer	2.4e-06	5.84e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CA—colon cancer	2.36e-06	5.75e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.32e-06	5.66e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—colon cancer	2.31e-06	5.63e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EP300—colon cancer	2.3e-06	5.61e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—EP300—colon cancer	2.29e-06	5.59e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SRC—colon cancer	2.24e-06	5.45e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—colon cancer	2.23e-06	5.42e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—colon cancer	2.22e-06	5.41e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—colon cancer	2.18e-06	5.31e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—colon cancer	2.18e-06	5.3e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NRAS—colon cancer	2.15e-06	5.24e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PPARG—colon cancer	2.14e-06	5.21e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CA—colon cancer	2.13e-06	5.2e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.12e-06	5.16e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PPARG—colon cancer	2.09e-06	5.09e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—colon cancer	2.06e-06	5.01e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CA—colon cancer	2.05e-06	5e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—colon cancer	2e-06	4.88e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TGFB1—colon cancer	2e-06	4.87e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—colon cancer	1.98e-06	4.81e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PPARG—colon cancer	1.97e-06	4.79e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—colon cancer	1.96e-06	4.78e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PPARG—colon cancer	1.95e-06	4.75e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—colon cancer	1.93e-06	4.7e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—EP300—colon cancer	1.93e-06	4.69e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—colon cancer	1.88e-06	4.59e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CA—colon cancer	1.87e-06	4.55e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—colon cancer	1.85e-06	4.51e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CA—colon cancer	1.85e-06	4.51e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—EP300—colon cancer	1.85e-06	4.51e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ABCB1—colon cancer	1.85e-06	4.5e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TYMS—colon cancer	1.82e-06	4.42e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—EP300—colon cancer	1.81e-06	4.42e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—EP300—colon cancer	1.81e-06	4.41e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—colon cancer	1.74e-06	4.25e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—EP300—colon cancer	1.71e-06	4.17e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CA—colon cancer	1.7e-06	4.15e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CA—colon cancer	1.7e-06	4.14e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—colon cancer	1.68e-06	4.1e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—colon cancer	1.68e-06	4.09e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—colon cancer	1.64e-06	4e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—colon cancer	1.57e-06	3.84e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—EP300—colon cancer	1.57e-06	3.82e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—colon cancer	1.55e-06	3.77e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—colon cancer	1.53e-06	3.74e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—colon cancer	1.53e-06	3.72e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—colon cancer	1.51e-06	3.69e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CA—colon cancer	1.43e-06	3.47e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—EP300—colon cancer	1.4e-06	3.41e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—colon cancer	1.39e-06	3.39e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—colon cancer	1.39e-06	3.38e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CA—colon cancer	1.37e-06	3.34e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—EP300—colon cancer	1.37e-06	3.33e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CA—colon cancer	1.34e-06	3.27e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CA—colon cancer	1.34e-06	3.26e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—EP300—colon cancer	1.29e-06	3.14e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPARG—colon cancer	1.29e-06	3.13e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—EP300—colon cancer	1.28e-06	3.11e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CA—colon cancer	1.26e-06	3.08e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—colon cancer	1.16e-06	2.84e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CA—colon cancer	1.16e-06	2.83e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—colon cancer	1.12e-06	2.73e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—colon cancer	1.1e-06	2.67e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—colon cancer	1.09e-06	2.66e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CA—colon cancer	1.04e-06	2.52e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—colon cancer	1.03e-06	2.52e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—colon cancer	1.01e-06	2.47e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CA—colon cancer	1.01e-06	2.46e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CA—colon cancer	9.52e-07	2.32e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—colon cancer	9.47e-07	2.31e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CA—colon cancer	9.44e-07	2.3e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—colon cancer	8.46e-07	2.06e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—EP300—colon cancer	8.41e-07	2.05e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—colon cancer	8.25e-07	2.01e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—colon cancer	7.78e-07	1.89e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—colon cancer	7.71e-07	1.88e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CA—colon cancer	6.22e-07	1.52e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—colon cancer	5.08e-07	1.24e-05	CbGpPWpGaD
